Correlation Engine 2.0
Clear Search sequence regions


  • blood (1)
  • CCL2 (2)
  • CXCL8 (3)
  • flow (1)
  • help (1)
  • IL 10 (3)
  • IL 8 (3)
  • interferon γ (1)
  • interleukin (1)
  • levels protein (1)
  • lung edema (6)
  • lymphocytes (3)
  • MCP 1 (2)
  • monocyte (1)
  • neutrophils (2)
  • oxygen (1)
  • patients (3)
  • plasma (2)
  • platelet (2)
  • supply (2)
  • therapies (1)
  • TNF (1)
  • tumor necrosis factor α (1)
  • Sizes of these terms reflect their relevance to your search.

    Coronavirus disease 2019 (COVID-19) has placed enormous pressure on intensive care units (ICUs) and on healthcare systems in general. A deeper understanding of the pathophysiology of the most severe forms of COVID-19 would help guide the development of more effective interventions. Herein, we characterized the inflammatory state of patients with COVID-19 of varying degrees of severity to identify admission biomarkers for predicting COVID-19 worsening. Admission blood samples were obtained from 78 patients with COVID-19. Radiographic assessment of lung edema (RALE) scoring was calculated by imaging. Platelet and leukocyte counts were measured by flow cytometry, and plasma levels of C-reactive protein were assessed by immunoturbidimetry, and interleukin (IL)-8/CXCL8, IL-10, tumor necrosis factor (TNF)-α, interferon (IFN)-γ, and monocyte chemoattractant protein-1 (MCP-1/CCL2) levels by enzyme-linked immunosorbent assay (ELISA). The RALE score correlated with several admission hemogram (platelets, neutrophils, and lymphocytes) and inflammatory (IL-8/CXCL8, MCP-1/CCL2, IL-10, and C-reactive protein) parameters. COVID-19 worsening, based on the need for oxygen (Δoxygen supply) during hospitalization, correlated negatively with admission lymphocyte counts but positively with neutrophil-to-lymphocyte ratio and with plasma levels of the inflammatory parameters correlating with RALE score. Our data indicate a correlation between the RALE score and Δoxygen supply and admission inflammatory status. The identification of a panel of biomarkers that reflect COVID severity might be useful to predict disease worsening during hospitalization and to guide clinical management of COVID-19-related complications. Finally, therapies targeting IL-8/CXCL8- or IL-10 activity may offer therapeutic approaches in COVID-19 treatment. Copyright © 2022 Marques, Fernandez-Presa, Carretero, Gómez-Cabrera, Viña, Signes-Costa and Sanz.

    Citation

    Patrice Marques, Lucia Fernandez-Presa, Aitor Carretero, Maria-Carmen Gómez-Cabrera, José Viña, Jaime Signes-Costa, Maria-Jesus Sanz. The radiographic assessment of lung edema score of lung edema severity correlates with inflammatory parameters in patients with coronavirus disease 2019-Potential new admission biomarkers to predict coronavirus disease 2019 worsening. Frontiers in medicine. 2022;9:871714


    PMID: 36035415

    View Full Text